Acknowledgements
P.
This study was funded by Kite, a Gilead company. We thank the patients, their families and the study personnel involved in this trial. We also thank the ALYCANTE investigators, P. Cony-Makhoul, E. Chareyre and the LYSARC study team (Supplementary Table 